Detection of Nasal Solitary Extramedullary Plasmacytoma on 18F-FDG PET/CT Imaging

Clinical Nuclear Medicine
|February 25, 2021
PubMed

Insights

A solitary nasal extramedullary plasmacytoma, a rare cancer, was diagnosed in a man with recurrent epistaxis. Treatment with radiation therapy provided symptom relief, highlighting effective localized management for this uncommon condition.

Area of Science:

  • Oncology
  • Radiology
  • Pathology

Background:

  • Extramedullary plasmacytoma (EMP) is a rare plasma cell neoplasm occurring outside the bone marrow.
  • Nasal cavity involvement is uncommon, presenting diagnostic challenges.
  • Early diagnosis and treatment are crucial for patient outcomes.

Observation:

  • A 46-year-old man presented with a 3-month history of epistaxis.
  • Imaging (CT and MRI) revealed a soft tissue mass in the left nasal cavity.
  • Excisional biopsy confirmed extramedullary plasmacytoma.

Findings:

  • 18F-FDG PET/CT demonstrated intense activity in the nasal mass, with no evidence of systemic disease.
  • The patient was diagnosed with solitary nasal extramedullary plasmacytoma.
  • Workup excluded multiple myeloma or other systemic plasma cell disorders.

Implications:

  • Solitary nasal extramedullary plasmacytoma requires a high index of suspicion for accurate diagnosis.
  • Localized radiation therapy can be an effective treatment modality.
  • This case underscores the importance of thorough workup to rule out systemic disease.